# Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

> **NCT00261820** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 160 (—)

## Conditions studied

- Graft Rejection
- Kidney Failure
- Kidney Transplantation

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** methylprednisolone
- **DRUG:** prednisolone
- **DRUG:** sirolimus

## Key facts

- **NCT ID:** NCT00261820
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 160 (—)
- **Last updated:** 2006-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261820, "Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00261820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*